PAR-2 deficient CD4+ T cells exhibit downregulation of IL-4 and upregulation of IFN-γ after antigen challenge in mice

Allergology International

Volumn 55, Issue 3, 2006, Pages 271-278

  Shichijo, Michitaka ^a,c   Kondo, Shinichi ^a   Ishimori, Mina ^a   Watanabe, Shinichi ^a   Helin, Heidi ^a   Yamasaki, Tsugiko ^a   Stevens, Mary E ^b   Gantner, Florian ^a   Bacon, Kevin B ^a  

^a BAYER YAKUHIN LTD   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Discovery Research Laboratories   (Japan)

Author keywords

GATA 3; JNK1; PAR 2; T bet

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PROTEINASE ACTIVATED RECEPTOR 2;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CD4 LYMPHOCYTE COUNT; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME PHOSPHORYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; WESTERN BLOTTING;

EID: 33748921366     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.55.271     Document Type: Article

References (29)

1. Nystedt S, Emilsson K, Wahlestedt C, Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proc. Natl. Acad. Sci. U.S.A. 1994;91:9208-9212.
2. Nystedt S, Larsson A-K, Åberg H, Sundelin J. The mouse proteinase-activated receptor-2 cDNA and gene. J. Biol. Chem. 1995;270:5950-5955.
3. Dery O, Corvera CU, Steinhoff M, Bunnett NW. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am. J. Physiol. 1998;274:C1429-1452.
4. Hollenberg MD, Compton S. International Union of Pharmacology. XX-VIII. Proteinase-Activated Receptors. Pharmacol. Rev. 2002;54:203-217.
5. Molino M, Barnathan ES, Numerof R et al. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J. Biol. Chem. 1997;272:4043-4049.
6. Fox MT, Harriott P, Walker B, Stone SR. Identification of potential activators of proteinase-activated receptor-2. FEBS Lett. 1997;417:267-269.
7. Camerer E, Huang W, Coughlin SR. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc. Natl. Acad. Sci. U.S.A. 2000;97:5255-5260.
8. Nystedt S, Ramakrishnan V, Sundelin J. The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. J. Biol. Chem. 1996;271:14910-14915.
9. Vergnolle N. Proteinase-activated receptor-2-activating peptides induce leukocyte rolling, adhesion, and extravasation in vivo. J. Immunol. 1999;163:5064-5069.
10. Kawabata A, Kuroda R, Minami T, Kataoka K, Taneda M. Increased vascular permeability by a specific agonist of protease-activated receptor-2 in rat hindpaw. Brit. J. Pharmacol. 1998;125:419-422.
11. Vergnolle N, Hollengerg MD, Sharkey KA, Wallace JL. Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw. Brit. J. Pharmacol. 1999;127:1083-1090.
12. Kawagoe J, Takizawa T, Matsumoto J et al. Effect of protease-activated receptor-2 deficiency on allergic dermatitis in the mouse ear. Jpn. J. Pharmacol. 2002;88:77-84.
13. Schmidlin F, Amadesi S, Dabbagh K et al. Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J. Immunol. 2002;169:5315-5321.
14. Kon OM, Kay AB. T cells and chronic asthma. Int. Arch. Allergy Immunol. 1999;118:133-135.
15. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 1999;17:255-281.
16. Humbert M, Menz G, Ying S et al. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol. Today 1999;20:528-533.
17. Knight DA, Lim S, Scaffidi AK et al. Protease-activated receptors in human airways: Upregulation of PAR-2 in respiratory epithelium from patients with asthma. J. Allergy Clin. Immunol. 2001;108:797-803.
18. Cohn L, Homer RJ, Marinov A, Rankin J, Bottomly K. Induction of airway mucus production by T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J. Exp. Med. 1997;186:1737-1747.
19. Simpson EM, Linder CC, Sargent EE, Davisson MT, Mobraaten LE, Sharp JJ. Genetic variation among 129 substrains and its importance for targeted mutagenesis. J Nature 1997;16:19-27.
20. Grogan JL, Mohrs M, Harmon B, Lacy DA, Sedat JW, Locksley RM. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 2001;14:205-215.
21. Ebeling C, Forsythe P, Ng J et al. Protease-activated receptor 2 activation in the airways enhances antigen-mediated airway inflammation and airway hyperresponsiveness through different pathways. J. Allergy Clin. Immunol. 2005;115:623-630.
22. Takizawa T, Tamiya M, Hara T et al. Abrogation of bronchial eosinophilic inflammation and attenuated eotaxin content in protease-activated receptor 2-deficient mice. J. Pharmacol. Sci. 2005;98:99-102.
23. Ferrell WR, Lockhart JC, Kelso EB et al. Essential role for protease-activated receptor-2 in arthritis. J. Clin. Invest. 2003;111:35-41.
24. Joyce DE, Chen Y, Erger RA, Koretzky GA, Lentz SR. Functional interactions between the thrombin receptor and the T-cell antigen receptor in human T-cell lines. Blood 1997;90:1893-1901.
25. Bar-Shavit R, Maoz M, Yongjun Y, Groysman M, Dekel I, Katzav S. Signalling pathways induced by protease-activated receptors and integrins in T cells. Immunology 2002;105:35-46.
26. Flavell RA, Li B, Dong C et al. Molecular basis of T-cell differentiation. Cold Spring Harb. Symp. Quant. Biol. 1999;64:563-571.
27. Dong C, Yang DD, Wysk M, Whitmarsh AJ, Davis RJ, Flavell RA. Defective T cell differentiation in the absence of JNK1. Science 1998;282:2092-2095.
28. + T cells to Th1 cells requires MAP kinase JNK2. Immunity 1998;9:575-585.
29. Fields RC, Schoenecker JG, Hart JP, Hoffman MR, Pizzo SV, Lawson JH. Protease-activated receptor-2 signaling triggers dendritic cell development. Am. J. Pathol. 2003;162:1817-1822.